Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност
  • Място
  • Местоположение
  • дивизия Sort descending
  • Бизнес
  • Functional Area
  • Дата
Длъжност Място Местоположение дивизия Sort descending Бизнес Functional Area Дата
ABL - RLT Field Sales (USA) USA US Innovative Medicines Sales Апр. 30, 2024
Allergy-Territory Account Specialist – Portland, OR – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 08, 2024
Allergy Territory Account Specialist – Pasadena, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 08, 2024
Allergy-Territory Account Specialist – Minneapolis, MN – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 09, 2024
Allergy-Territory Account Specialist – Kansas City, MO – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 09, 2024
Allergy- Territory Account Specialist – Akron, OH– Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 10, 2024
Allergy-Territory Account Specialist – Flint, MI – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 10, 2024
Allergy-Territory Account Specialist – Ann Arbor, MI – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 10, 2024
Allergy Territory Account Specialist - Chicago, IL (South) - Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 11, 2024
Allergy-Territory Account Specialist – Toldeo, OH – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 13, 2024
349145BR - Director, Channel Enablement and Optimization Governance East Hanover USA US Innovative Medicines Marketing Септ. 13, 2024
Cardiovascular Institutional Sales Specialist– Boston – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 17, 2024
Allergy Territory Account Specialist - Los Angeles, CA (East) - Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 23, 2024
Allergy Territory Account Specialist - Chicago, IL (North) - Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 23, 2024
Allergy-Territory Account Specialist – Wichita, KS – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 24, 2024
AD, Patient Support Center - Program Monitoring Arizona USA US Innovative Medicines Quality Окт. 04, 2024
Cardiovascular Territory Account Specialist (Part-Time) – Bakersfield, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Окт. 04, 2024
Associate Director, Curriculum Design East Hanover USA US Innovative Medicines Sales Окт. 04, 2024
Allergy-Territory Account Specialist – Fort Wayne, IN – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 25, 2024
Allergy- Territory Account Specialist – San Francisco, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 27, 2024
Allergy- Territory Account Specialist – Detroit, MI – Remote Field Sales (USA) USA US Innovative Medicines Sales Септ. 30, 2024
Director Account Management and Pricing Strategy - Remote Remote Position (USA) USA US Innovative Medicines Market Access Окт. 08, 2024
Medical Science Liaison Onc Prostate Radioligand Therapies Michigan Territory Field Non-Sales (USA) USA US Innovative Medicines Research & Development Окт. 09, 2024
Allergy Territory Account Specialist – Queens, NY – Remote Queens (New York) USA US Innovative Medicines Sales Окт. 15, 2024
Associate Director, Workforce Forecasting & Capacity Planning Arizona USA US Innovative Medicines Sales Окт. 15, 2024
Allergy-Territory Account Specialist – Seattle E, WA – Remote Field Sales (USA) USA US Innovative Medicines Sales Окт. 11, 2024
Neuroscience Territory Account Specialist – Denver - Remote Field Sales (USA) USA US Innovative Medicines Sales Окт. 12, 2024
Rheumatology Territory Account Specialist – Denver Metro - Remote Field Sales (USA) USA US Innovative Medicines Sales Окт. 14, 2024
Associate Director, Digital Analytics - HQ based - East Hanover, NJ East Hanover USA US Innovative Medicines Marketing Окт. 09, 2024
Dermatology Territory Account Specialist – Boston South – Remote Field Sales (USA) USA US Innovative Medicines Sales Окт. 10, 2024
Dermatology Territory Account Specialist – Portland ME – Remote Field Sales (USA) USA US Innovative Medicines Sales Окт. 10, 2024
RLT Customer Support INSURGENTES Mexico US Innovative Medicines Technical Operations Окт. 10, 2024
Rheumatology Territory Account Specialist – Houston West – Remote Field Sales (USA) USA US Innovative Medicines Sales Окт. 10, 2024
Neuroscience-Territory Account Specialist – San Jose, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Окт. 01, 2024
Associate Director, Access & Reimbursement Oncology - Remote - TX,OK, AR Field Non-Sales (USA) USA US Innovative Medicines Market Access Окт. 16, 2024
AD, Market Access TA Strategy- Breast & Women's Cancer East Hanover USA US Innovative Medicines Market Access Окт. 16, 2024
Associate Director, Marketing Strategist - Immunology East Hanover USA US Innovative Medicines Marketing Окт. 16, 2024
Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ Field Non-Sales (USA) USA US Innovative Medicines Research & Development Окт. 17, 2024
AD, Access & Reimbursement - Minneapolis - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Окт. 17, 2024
Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Окт. 17, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България